PAR-24-124 - NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI): Research Opportunities Centering the Health of Women Across the HIV Research Continuum |
NOT-OD-24-119 |
ORWH , FIC , NCCIH , NCI , NIA , NIAAA , NIAID , NIAMS , NICHD , NIDA , NIDDK , NIMH , NIMHD , NINDS , OAR , OBSSR , SGMRO
|
May 21, 2024 |
Jan 8, 2026
|
K99/R00, R01, R34, F32, K23, K25, K02, R15, K01, K43, R21, K24, R61/R33, K08, F30, R03, DP1, U34, F31, T32, R36 |
Notice of Special Interest (NOSI): Interventions to Reduce Chronic Inflammation and Inflammation-Related Morbidity in People Living with HIV/AIDS |
NOT-AT-24-035 |
NCCIH , NIA
|
Mar 4, 2024 |
Nov 14, 2024
|
R01, R61/R33, R34, R21 |
Notice of Special Interest (NOSI): Accelerating Progress in Celiac Disease Research |
NOT-AI-22-004 |
NIAID , NIAMS , NCCIH , NCI
|
Nov 23, 2021 |
Jan 8, 2025
|
R03, R21, U01, U44, R01, R34, P01, R61/R33 |
Expired NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
|